Pharmaceuticals in Germany

Pharmaceuticals in Germany


  • Products Id :- OHMF4446
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Germany

Summary

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The German pharmaceuticals market had total revenues of USD 71.3bn in 2017, representing a compound annual growth rate (CAGR) of 7.1% between 2013 and 2017.

- Infrastructure support in Germany is strong for both foreign and domestic companies, which has encouraged investment in research and development centres and the construction of new manufacturing plants.

- An aging population should serve to increase spending; however, governments are under pressure to keep a lid on spending, potentially constraining growth in the market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Germany pharmaceuticals market by value in 2017?

- What will be the size of the Germany pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Germany pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Germany's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Bayer AG 23

Boehringer Ingelheim GmbH 27

Novartis AG 30

F. Hoffmann-La Roche Ltd 33

Macroeconomic Indicators 36

Country data 36

Methodology 38

Industry associations 39

Related MarketLine research 39

Appendix 40

About MarketLine 40

List of Figures

Figure 1: Germany pharmaceuticals market value: USD billion, 2013-17

Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Germany pharmaceuticals market share: % share, by value, 2017

Figure 4: Germany pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Germany, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Germany, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Germany, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017

Figure 11: Bayer AG: revenues & profitability

Figure 12: Bayer AG: assets & liabilities

Figure 13: Boehringer Ingelheim GmbH: revenues & profitability

Figure 14: Boehringer Ingelheim GmbH: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities

List of Tables

Table 1: Germany pharmaceuticals market value: USD billion, 2013-17

Table 2: Germany pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Germany pharmaceuticals market share: % share, by value, 2017

Table 4: Germany pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Bayer AG: key facts

Table 6: Bayer AG: key financials (USD )

Table 7: Bayer AG: key financials (EUR)

Table 8: Bayer AG: key financial ratios

Table 9: Boehringer Ingelheim GmbH: key facts

Table 10: Boehringer Ingelheim GmbH: key financials (USD )

Table 11: Boehringer Ingelheim GmbH: key financials (EUR)

Table 12: Boehringer Ingelheim GmbH: key financial ratios

Table 13: Novartis AG: key facts

Table 14: Novartis AG: key financials (USD )

Table 15: Novartis AG: key financial ratios

Table 16: F. Hoffmann-La Roche Ltd: key facts

Table 17: F. Hoffmann-La Roche Ltd: key financials (USD )

Table 18: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 19: F. Hoffmann-La Roche Ltd: key financial ratios

Table 20: Germany size of population (million), 2013-17

Table 21: Germany gdp (constant 2005 prices, USD billion), 2013-17

Table 22: Germany gdp (current prices, USD billion), 2013-17

Table 23: Germany inflation, 2013-17

Table 24: Germany consumer price index (absolute), 2013-17

Table 25: Germany exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24150
Site License
USD 700 INR 48300
Corporate User License
USD 1050 INR 72450

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com